FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023370629> ?p ?o ?g. }

• W2023370629 endingPage "1195" @default.
• W2023370629 startingPage "1187" @default.
• W2023370629 abstract "The efficacy and safety of sirolimus (SRL) plus tacrolimus (TAC) versus SRL plus cyclosporine (CsA) were compared in high-risk renal allograft recipients.Evaluable patients (448) were randomly assigned (1:1) before transplant to receive SRL+TAC or SRL+CsA with corticosteroids. Eligible patients were black and/or repeat transplant recipients, and/or those with high titer of panel-reactive antibodies.Demographics were similar between groups. Both treatments demonstrated equivalent efficacy of the composite endpoint at 12 months with efficacy failure rates of 21.9% vs. 23.2% (SRL+TAC vs. SRL+CsA, respectively, 95% CI -10.0 to 7.1, P=0.737). Biopsy-confirmed acute rejection rate (13.8% vs. 17.4%) and graft survival rate (89.7% vs. 90.2%) were similar (SRL+TAC vs. SRL+CsA, respectively). In evaluable patients (received at least 1 dose of study drug), renal function (calculated Nankivell glomerular filtration rate) was not superior in SRL+TAC versus SRL+CsA (54.5 vs. 52.6 mL/min, P=0.466); however, in on-therapy patients, glomerular filtration rate was significantly higher in SRL+TAC at most time points. At 12 months, there were no significant differences in rates of death, discontinuation because of adverse events, hypercholesterolemia, hyperlipemia, or proteinuria. Diarrhea and herpes simplex infections occurred significantly more often in SRL+TAC patients. Hypertension, cardiomegaly, increased creatinine, overdose (primarily calcineurin inhibitor toxicity), acne, urinary tract disorders, lymphocele, and ovarian cysts occurred significantly more often in SRL+CsA patients.This study demonstrated that SRL-based therapy was efficacious in high-risk renal allograft recipients in the first year after transplant, providing equivalent efficacy with CsA or TAC, similar graft survival, low biopsy-confirmed acute rejection rates, excellent renal function, and an acceptable safety profile." @default.
• W2023370629 created "2016-06-24" @default.
• W2023370629 creator A5011704380 @default.
• W2023370629 creator A5021921889 @default.
• W2023370629 creator A5028519941 @default.
• W2023370629 creator A5031863119 @default.
• W2023370629 creator A5053541119 @default.
• W2023370629 creator A5080341002 @default.
• W2023370629 date "2008-11-15" @default.
• W2023370629 modified "2023-09-25" @default.
• W2023370629 title "Comparison of Sirolimus Plus Tacrolimus Versus Sirolimus Plus Cyclosporine in High-Risk Renal Allograft Recipients: Results From an Open-Label, Randomized Trial" @default.
• W2023370629 cites W1986757474 @default.
• W2023370629 cites W2000531481 @default.
• W2023370629 cites W2003814657 @default.
• W2023370629 cites W2039553787 @default.
• W2023370629 cites W2047114489 @default.
• W2023370629 cites W2048737716 @default.
• W2023370629 cites W2048938245 @default.
• W2023370629 cites W2055808255 @default.
• W2023370629 cites W2057274477 @default.
• W2023370629 cites W2059333451 @default.
• W2023370629 cites W2063803293 @default.
• W2023370629 cites W2071307134 @default.
• W2023370629 cites W2072542208 @default.
• W2023370629 cites W2079276782 @default.
• W2023370629 cites W2095241070 @default.
• W2023370629 cites W2121772423 @default.
• W2023370629 cites W2147646452 @default.
• W2023370629 cites W2148724358 @default.
• W2023370629 cites W2150011576 @default.
• W2023370629 cites W2328786770 @default.
• W2023370629 doi "https://doi.org/10.1097/tp.0b013e318187bab0" @default.
• W2023370629 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19005398" @default.
• W2023370629 hasPublicationYear "2008" @default.
• W2023370629 type Work @default.
• W2023370629 sameAs 2023370629 @default.
• W2023370629 citedByCount "52" @default.
• W2023370629 countsByYear W20233706292012 @default.
• W2023370629 countsByYear W20233706292013 @default.
• W2023370629 countsByYear W20233706292014 @default.
• W2023370629 countsByYear W20233706292015 @default.
• W2023370629 countsByYear W20233706292016 @default.
• W2023370629 countsByYear W20233706292017 @default.
• W2023370629 countsByYear W20233706292019 @default.
• W2023370629 countsByYear W20233706292021 @default.
• W2023370629 countsByYear W20233706292022 @default.
• W2023370629 countsByYear W20233706292023 @default.
• W2023370629 crossrefType "journal-article" @default.
• W2023370629 hasAuthorship W2023370629A5011704380 @default.
• W2023370629 hasAuthorship W2023370629A5021921889 @default.
• W2023370629 hasAuthorship W2023370629A5028519941 @default.
• W2023370629 hasAuthorship W2023370629A5031863119 @default.
• W2023370629 hasAuthorship W2023370629A5053541119 @default.
• W2023370629 hasAuthorship W2023370629A5080341002 @default.
• W2023370629 hasBestOaLocation W20233706291 @default.
• W2023370629 hasConcept C126322002 @default.
• W2023370629 hasConcept C126894567 @default.
• W2023370629 hasConcept C141071460 @default.
• W2023370629 hasConcept C159641895 @default.
• W2023370629 hasConcept C168563851 @default.
• W2023370629 hasConcept C197934379 @default.
• W2023370629 hasConcept C203092338 @default.
• W2023370629 hasConcept C2777921159 @default.
• W2023370629 hasConcept C2909675724 @default.
• W2023370629 hasConcept C2911091166 @default.
• W2023370629 hasConcept C71924100 @default.
• W2023370629 hasConcept C90924648 @default.
• W2023370629 hasConceptScore W2023370629C126322002 @default.
• W2023370629 hasConceptScore W2023370629C126894567 @default.
• W2023370629 hasConceptScore W2023370629C141071460 @default.
• W2023370629 hasConceptScore W2023370629C159641895 @default.
• W2023370629 hasConceptScore W2023370629C168563851 @default.
• W2023370629 hasConceptScore W2023370629C197934379 @default.
• W2023370629 hasConceptScore W2023370629C203092338 @default.
• W2023370629 hasConceptScore W2023370629C2777921159 @default.
• W2023370629 hasConceptScore W2023370629C2909675724 @default.
• W2023370629 hasConceptScore W2023370629C2911091166 @default.
• W2023370629 hasConceptScore W2023370629C71924100 @default.
• W2023370629 hasConceptScore W2023370629C90924648 @default.
• W2023370629 hasIssue "9" @default.
• W2023370629 hasLocation W20233706291 @default.
• W2023370629 hasLocation W20233706292 @default.
• W2023370629 hasLocation W20233706293 @default.
• W2023370629 hasOpenAccess W2023370629 @default.
• W2023370629 hasPrimaryLocation W20233706291 @default.
• W2023370629 hasRelatedWork W1970601178 @default.
• W2023370629 hasRelatedWork W2009735756 @default.
• W2023370629 hasRelatedWork W2059697647 @default.
• W2023370629 hasRelatedWork W2071667523 @default.
• W2023370629 hasRelatedWork W2146159635 @default.
• W2023370629 hasRelatedWork W2148950609 @default.
• W2023370629 hasRelatedWork W2281336723 @default.
• W2023370629 hasRelatedWork W2399770488 @default.
• W2023370629 hasRelatedWork W4245168986 @default.
• W2023370629 hasRelatedWork W2002131722 @default.
• W2023370629 hasVolume "86" @default.
• W2023370629 isParatext "false" @default.
• W2023370629 isRetracted "false" @default.

• next